CN110973638A - 一种晶合胶囊及其制作工艺 - Google Patents
一种晶合胶囊及其制作工艺 Download PDFInfo
- Publication number
- CN110973638A CN110973638A CN201911171777.3A CN201911171777A CN110973638A CN 110973638 A CN110973638 A CN 110973638A CN 201911171777 A CN201911171777 A CN 201911171777A CN 110973638 A CN110973638 A CN 110973638A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- powder
- capsule
- micron
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 44
- 238000004519 manufacturing process Methods 0.000 title claims description 12
- 239000000843 powder Substances 0.000 claims abstract description 60
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 38
- 108010001441 Phosphopeptides Proteins 0.000 claims abstract description 21
- 239000005018 casein Substances 0.000 claims abstract description 21
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000021240 caseins Nutrition 0.000 claims abstract description 21
- 241001313857 Bletilla striata Species 0.000 claims abstract description 20
- 241000251730 Chondrichthyes Species 0.000 claims abstract description 20
- 210000000845 cartilage Anatomy 0.000 claims abstract description 20
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229920001287 Chondroitin sulfate Polymers 0.000 claims abstract description 19
- 229910000019 calcium carbonate Inorganic materials 0.000 claims abstract description 19
- 229940059329 chondroitin sulfate Drugs 0.000 claims abstract description 19
- MSWZFWKMSRAUBD-UHFFFAOYSA-N 2-Amino-2-Deoxy-Hexose Chemical compound NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims abstract description 18
- 241000096284 Gynochthodes officinalis Species 0.000 claims abstract description 18
- 150000004676 glycans Chemical class 0.000 claims abstract description 18
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 18
- 239000005017 polysaccharide Substances 0.000 claims abstract description 18
- 241000729173 Cirsium japonicum Species 0.000 claims abstract description 7
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 claims abstract 2
- 229960002061 ergocalciferol Drugs 0.000 claims abstract 2
- 235000001892 vitamin D2 Nutrition 0.000 claims abstract 2
- 239000011653 vitamin D2 Substances 0.000 claims abstract 2
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims description 35
- 238000002156 mixing Methods 0.000 claims description 28
- 238000003756 stirring Methods 0.000 claims description 21
- 241000123113 Phellinus igniarius Species 0.000 claims description 19
- 229930003316 Vitamin D Natural products 0.000 claims description 16
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 16
- 235000019166 vitamin D Nutrition 0.000 claims description 16
- 239000011710 vitamin D Substances 0.000 claims description 16
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 16
- 229940046008 vitamin d Drugs 0.000 claims description 16
- 239000013078 crystal Substances 0.000 claims description 15
- 238000004806 packaging method and process Methods 0.000 claims description 7
- 238000007873 sieving Methods 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 abstract description 5
- 241000123107 Phellinus Species 0.000 abstract 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 12
- 239000011575 calcium Substances 0.000 description 12
- 229910052791 calcium Inorganic materials 0.000 description 12
- 210000000988 bone and bone Anatomy 0.000 description 10
- 229940069978 calcium supplement Drugs 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 159000000007 calcium salts Chemical group 0.000 description 4
- 230000008021 deposition Effects 0.000 description 4
- 230000003467 diminishing effect Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000010392 Bone Fractures Diseases 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 206010017076 Fracture Diseases 0.000 description 2
- 206010061599 Lower limb fracture Diseases 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 229940124532 absorption promoter Drugs 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000037180 bone health Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- CBOJBBMQJBVCMW-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;hydrochloride Chemical compound Cl.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO CBOJBBMQJBVCMW-BTVCFUMJSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960001911 glucosamine hydrochloride Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000009916 joint effect Effects 0.000 description 1
- 210000001930 leg bone Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/10—Peat; Amber; Turf; Humus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Marine Sciences & Fisheries (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Hematology (AREA)
Abstract
本发明公开了一种晶合胶囊及其制作工艺,晶合胶囊组份按重量份数包括碳酸钙20‑30份、D‑氨基葡萄糖盐酸盐4‑8份、酪蛋白磷酸肽2‑4份、巴戟天多糖4‑10份、硫酸软骨素3‑9份、维生素D2‑6份、鲨鱼软骨粉5‑12份、微米珍珠粉3‑12份、微米琥珀粉6‑10份、桑黄提取物2‑6份、白及提取物2‑8份和大蓟提取物4‑10份,本发明制作工艺简单,制得的晶合胶囊促进钙的吸收,又能增加骨骼钙盐的沉积,从而提高骨骼对钙的利用,同时还具有强筋骨、降血糖、填精髓、抗菌消炎的功效。
Description
技术领域
本发明涉及保健胶囊技术领域,具体为一种晶合胶囊及其制作工艺。
背景技术
晶合胶囊的保健功能是增加骨密度,也就是常说的补钙、健骨,其配方成份有碳酸钙、氨基葡萄糖盐酸盐、硫酸软骨素、酪蛋白磷酸肽等常规的补钙健骨的物质,而随着年龄的增大,人老关节先老化,但关节补钙效果会比较差,一是钙比较难沉积,更重要的是关节常常会有炎症相伴,这就造成常规补钙产品不能有效解决关节补钙的问题。
中国专利号“2016109882035”公开了一种晶合胶囊的制备工艺,其具有一定的补钙和消炎效果,但是钙质吸收效果差,影响补钙效果,因此,有必要对现有晶合胶囊进行改进。
发明内容
本发明的目的在于提供一种晶合胶囊及其制作工艺,以解决上述背景技术中提出的问题。
为实现上述目的,本发明提供如下技术方案:一种晶合胶囊,晶合胶囊组份按重量份数包括碳酸钙20-30份、D-氨基葡萄糖盐酸盐4-8份、酪蛋白磷酸肽2-4份、巴戟天多糖4-10份、硫酸软骨素3-9份、维生素D2-6份、鲨鱼软骨粉5-12份、微米珍珠粉3-12份、微米琥珀粉6-10份、桑黄提取物2-6份、白及提取物2-8份和大蓟提取物4-10份。
优选的,晶合胶囊组份优选的成分配比包括碳酸钙25份、D-氨基葡萄糖盐酸盐6份、酪蛋白磷酸肽3份、巴戟天多糖7份、硫酸软骨素6份、维生素D4份、鲨鱼软骨粉9份、微米珍珠粉8份、微米琥珀粉8份、桑黄提取物4份、白及提取物5份和大蓟提取物7份。
优选的,其制作工艺包括以下步骤:
A、将D-氨基葡萄糖盐酸盐、巴戟天多糖、硫酸软骨素、维生素D、鲨鱼软骨粉充分混合后加入搅拌罐中低速搅拌,之后过80目筛,得到混合物A;
B、在混合物A中加入碳酸钙、酪蛋白磷酸肽、微米珍珠粉、微米琥珀粉、桑黄提取物、白及提取物和大蓟提取物充分混合后加入混合罐中混合,得到混合物B;
C、将混合物B采用充填机填入预先制作好的空心胶囊中;
D、最后将填充后的胶囊进行包装。
优选的,所述步骤A中搅拌速率为80-120转/分,时间为10min-14min。
与现有技术相比,本发明的有益效果是:本发明制作工艺简单,制得的晶合胶囊促进钙的吸收,又能增加骨骼钙盐的沉积,从而提高骨骼对钙的利用,同时还具有强筋骨、降血糖、填精髓、抗菌消炎的功效;其中,本发明中利用酪蛋白磷酸肽作为矿物质吸收促进剂,有效增加钙元素的吸收率,具有预防和改善骨质疏松症、促进骨折患者的康复、补充钙营养元素等功效;添加的鲨鱼软骨粉、微米珍珠粉、微米琥珀粉增加了骨骼钙盐的沉积,从而提高了骨骼对钙的利用;另外,本发明中添加的桑黄提取物、白及提取物和大蓟提取物能够起到抗菌消炎的功效,还能够防止钙流失。
具体实施方式
下面对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
本发明提供如下技术方案:一种晶合胶囊,晶合胶囊组份按重量份数包括碳酸钙20-30份、D-氨基葡萄糖盐酸盐4-8份、酪蛋白磷酸肽2-4份、巴戟天多糖4-10份、硫酸软骨素3-9份、维生素D2-6份、鲨鱼软骨粉5-12份、微米珍珠粉3-12份、微米琥珀粉6-10份、桑黄提取物2-6份、白及提取物2-8份和大蓟提取物4-10份。
实施例一:
晶合胶囊组份按重量份数包括碳酸钙20份、D-氨基葡萄糖盐酸盐4份、酪蛋白磷酸肽2份、巴戟天多糖4份、硫酸软骨素3份、维生素D2份、鲨鱼软骨粉5份、微米珍珠粉3份、微米琥珀粉6份、桑黄提取物2份、白及提取物2份和大蓟提取物4份。
本实施例的制作工艺包括以下步骤:
A、将D-氨基葡萄糖盐酸盐、巴戟天多糖、硫酸软骨素、维生素D、鲨鱼软骨粉充分混合后加入搅拌罐中低速搅拌,之后过80目筛,得到混合物A;
B、在混合物A中加入碳酸钙、酪蛋白磷酸肽、微米珍珠粉、微米琥珀粉、桑黄提取物、白及提取物和大蓟提取物充分混合后加入混合罐中混合,得到混合物B;
C、将混合物B采用充填机填入预先制作好的空心胶囊中;
D、最后将填充后的胶囊进行包装。
本实施例中,步骤A中搅拌速率为80转/分,时间为10min。
实施例二:
晶合胶囊组份按重量份数包括碳酸钙30份、D-氨基葡萄糖盐酸盐8份、酪蛋白磷酸肽4份、巴戟天多糖10份、硫酸软骨素9份、维生素D6份、鲨鱼软骨粉12份、微米珍珠粉12份、微米琥珀粉10份、桑黄提取物6份、白及提取物8份和大蓟提取物10份。
本实施例的制作工艺包括以下步骤:
A、将D-氨基葡萄糖盐酸盐、巴戟天多糖、硫酸软骨素、维生素D、鲨鱼软骨粉充分混合后加入搅拌罐中低速搅拌,之后过80目筛,得到混合物A;
B、在混合物A中加入碳酸钙、酪蛋白磷酸肽、微米珍珠粉、微米琥珀粉、桑黄提取物、白及提取物和大蓟提取物充分混合后加入混合罐中混合,得到混合物B;
C、将混合物B采用充填机填入预先制作好的空心胶囊中;
D、最后将填充后的胶囊进行包装。
本实施例中,步骤A中搅拌速率为120转/分,时间为14min。
实施例三:
晶合胶囊组份按重量份数包括碳酸钙22份、D-氨基葡萄糖盐酸盐5份、酪蛋白磷酸肽2份、巴戟天多糖6份、硫酸软骨素4份、维生素D3份、鲨鱼软骨粉6份、微米珍珠粉5份、微米琥珀粉7份、桑黄提取物3份、白及提取物3份和大蓟提取物5份。
本实施例的制作工艺包括以下步骤:
A、将D-氨基葡萄糖盐酸盐、巴戟天多糖、硫酸软骨素、维生素D、鲨鱼软骨粉充分混合后加入搅拌罐中低速搅拌,之后过80目筛,得到混合物A;
B、在混合物A中加入碳酸钙、酪蛋白磷酸肽、微米珍珠粉、微米琥珀粉、桑黄提取物、白及提取物和大蓟提取物充分混合后加入混合罐中混合,得到混合物B;
C、将混合物B采用充填机填入预先制作好的空心胶囊中;
D、最后将填充后的胶囊进行包装。
本实施例中,步骤A中搅拌速率为90转/分,时间为11min。
实施例四:
晶合胶囊组份按重量份数包括碳酸钙28份、D-氨基葡萄糖盐酸盐7份、酪蛋白磷酸肽3份、巴戟天多糖8份、硫酸软骨素8份、维生素D5份、鲨鱼软骨粉10份、微米珍珠粉10份、微米琥珀粉9份、桑黄提取物5份、白及提取物7份和大蓟提取物8份。
本实施例的制作工艺包括以下步骤:
A、将D-氨基葡萄糖盐酸盐、巴戟天多糖、硫酸软骨素、维生素D、鲨鱼软骨粉充分混合后加入搅拌罐中低速搅拌,之后过80目筛,得到混合物A;
B、在混合物A中加入碳酸钙、酪蛋白磷酸肽、微米珍珠粉、微米琥珀粉、桑黄提取物、白及提取物和大蓟提取物充分混合后加入混合罐中混合,得到混合物B;
C、将混合物B采用充填机填入预先制作好的空心胶囊中;
D、最后将填充后的胶囊进行包装。
本实施例中,步骤A中搅拌速率为110转/分,时间为13min。
实施例五:
晶合胶囊组份按重量份数包括碳酸钙25份、D-氨基葡萄糖盐酸盐6份、酪蛋白磷酸肽3份、巴戟天多糖7份、硫酸软骨素6份、维生素D4份、鲨鱼软骨粉9份、微米珍珠粉8份、微米琥珀粉8份、桑黄提取物4份、白及提取物5份和大蓟提取物7份。
本实施例的制作工艺包括以下步骤:
A、将D-氨基葡萄糖盐酸盐、巴戟天多糖、硫酸软骨素、维生素D、鲨鱼软骨粉充分混合后加入搅拌罐中低速搅拌,之后过80目筛,得到混合物A;
B、在混合物A中加入碳酸钙、酪蛋白磷酸肽、微米珍珠粉、微米琥珀粉、桑黄提取物、白及提取物和大蓟提取物充分混合后加入混合罐中混合,得到混合物B;
C、将混合物B采用充填机填入预先制作好的空心胶囊中;
D、最后将填充后的胶囊进行包装。
本实施例中,步骤A中搅拌速率为105转/分,时间为11min。
案例:
患者吕某,65岁,一个月前摔跤造成腿部骨折,通过束缚带进行绑扎,同时恢复期间服用本发明制得的晶合胶囊,连续服用2个月后,腿部骨折处已痊愈,遗留的关节、腿骨疼痛症状明显缓解,继续服用3个月后,关节活动灵活。
患者卞某,70岁,半年前手掌骨裂,恢复后,手掌经常疼痛,后服用本发明制得的晶合胶囊,连续服用3个月后,疼痛症状明显缓解,继续服用两个月,疼痛症状消失,活动灵活。
综上所述,本发明制作工艺简单,制得的晶合胶囊促进钙的吸收,又能增加骨骼钙盐的沉积,从而提高骨骼对钙的利用,同时还具有强筋骨、降血糖、填精髓、抗菌消炎的功效;其中,本发明中利用酪蛋白磷酸肽作为矿物质吸收促进剂,有效增加钙元素的吸收率,具有预防和改善骨质疏松症、促进骨折患者的康复、补充钙营养元素等功效;添加的鲨鱼软骨粉、微米珍珠粉、微米琥珀粉增加了骨骼钙盐的沉积,从而提高了骨骼对钙的利用;另外,本发明中添加的桑黄提取物、白及提取物和大蓟提取物能够起到抗菌消炎的功效,还能够防止钙流失。
尽管已经示出和描述了本发明的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由所附权利要求及其等同物限定。
Claims (4)
1.一种晶合胶囊,其特征在于:晶合胶囊组份按重量份数包括碳酸钙20-30份、D-氨基葡萄糖盐酸盐4-8份、酪蛋白磷酸肽2-4份、巴戟天多糖4-10份、硫酸软骨素3-9份、维生素D2-6份、鲨鱼软骨粉5-12份、微米珍珠粉3-12份、微米琥珀粉6-10份、桑黄提取物2-6份、白及提取物2-8份和大蓟提取物4-10份。
2.根据权利要求1所述的一种晶合胶囊,其特征在于:晶合胶囊组份优选的成分配比包括碳酸钙25份、D-氨基葡萄糖盐酸盐6份、酪蛋白磷酸肽3份、巴戟天多糖7份、硫酸软骨素6份、维生素D4份、鲨鱼软骨粉9份、微米珍珠粉8份、微米琥珀粉8份、桑黄提取物4份、白及提取物5份和大蓟提取物7份。
3.实现权利要求1所述的一种晶合胶囊的制作工艺,其特征在于:其制作工艺包括以下步骤:
A、将D-氨基葡萄糖盐酸盐、巴戟天多糖、硫酸软骨素、维生素D、鲨鱼软骨粉充分混合后加入搅拌罐中低速搅拌,之后过80目筛,得到混合物A;
B、在混合物A中加入碳酸钙、酪蛋白磷酸肽、微米珍珠粉、微米琥珀粉、桑黄提取物、白及提取物和大蓟提取物充分混合后加入混合罐中混合,得到混合物B;
C、将混合物B采用充填机填入预先制作好的空心胶囊中;
D、最后将填充后的胶囊进行包装。
4.根据权利要求3所述的一种晶合胶囊的制作工艺,其特征在于:所述步骤A中搅拌速率为80-120转/分,时间为10min-14min。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911171777.3A CN110973638A (zh) | 2019-11-26 | 2019-11-26 | 一种晶合胶囊及其制作工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911171777.3A CN110973638A (zh) | 2019-11-26 | 2019-11-26 | 一种晶合胶囊及其制作工艺 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110973638A true CN110973638A (zh) | 2020-04-10 |
Family
ID=70087036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911171777.3A Pending CN110973638A (zh) | 2019-11-26 | 2019-11-26 | 一种晶合胶囊及其制作工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110973638A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115819641A (zh) * | 2022-12-30 | 2023-03-21 | 康道生物(南通)有限公司 | 一种改性硫酸软骨素及其制备方法和药物组合物 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1121417A (zh) * | 1995-01-27 | 1996-05-01 | 严镇琪 | 珍珠牡蛎补钙制剂 |
CN1903220A (zh) * | 2006-07-12 | 2007-01-31 | 江中药业股份有限公司 | 一种具有增加骨密度功能的保健食品及其制备方法 |
CN101015682A (zh) * | 2007-02-01 | 2007-08-15 | 甘肃奇正藏药有限公司 | 具有增加骨密度功能的药物组合物及制备和质量控制方法 |
CN102178933A (zh) * | 2011-04-20 | 2011-09-14 | 威海康博尔生物药业有限公司 | 一种用于防治骨质疏松症及骨关节病的制剂 |
CN102805858A (zh) * | 2012-08-29 | 2012-12-05 | 山东省疾病预防控制中心 | 一种高效补钙胶囊及制备方法 |
CN106562423A (zh) * | 2016-11-10 | 2017-04-19 | 康道生物(南通)有限公司 | 一种晶合胶囊的制备工艺 |
CN108543054A (zh) * | 2018-05-31 | 2018-09-18 | 广州聚澜健康产业研究院有限公司 | 一种补钙胶囊及其制备方法 |
CN108968075A (zh) * | 2018-07-05 | 2018-12-11 | 天津市益倍建生物技术有限公司 | 一种提高骨骼健康的组合物及其应用 |
-
2019
- 2019-11-26 CN CN201911171777.3A patent/CN110973638A/zh active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1121417A (zh) * | 1995-01-27 | 1996-05-01 | 严镇琪 | 珍珠牡蛎补钙制剂 |
CN1903220A (zh) * | 2006-07-12 | 2007-01-31 | 江中药业股份有限公司 | 一种具有增加骨密度功能的保健食品及其制备方法 |
CN101015682A (zh) * | 2007-02-01 | 2007-08-15 | 甘肃奇正藏药有限公司 | 具有增加骨密度功能的药物组合物及制备和质量控制方法 |
CN102178933A (zh) * | 2011-04-20 | 2011-09-14 | 威海康博尔生物药业有限公司 | 一种用于防治骨质疏松症及骨关节病的制剂 |
CN102805858A (zh) * | 2012-08-29 | 2012-12-05 | 山东省疾病预防控制中心 | 一种高效补钙胶囊及制备方法 |
CN106562423A (zh) * | 2016-11-10 | 2017-04-19 | 康道生物(南通)有限公司 | 一种晶合胶囊的制备工艺 |
CN108543054A (zh) * | 2018-05-31 | 2018-09-18 | 广州聚澜健康产业研究院有限公司 | 一种补钙胶囊及其制备方法 |
CN108968075A (zh) * | 2018-07-05 | 2018-12-11 | 天津市益倍建生物技术有限公司 | 一种提高骨骼健康的组合物及其应用 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115819641A (zh) * | 2022-12-30 | 2023-03-21 | 康道生物(南通)有限公司 | 一种改性硫酸软骨素及其制备方法和药物组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111616232A (zh) | 一种促进骨骼生长的儿童奶粉及其制备方法 | |
CN106135890A (zh) | 一种有助于骨关节健康的营养组合物 | |
CN107751387A (zh) | 一种有助于降低人体血糖的配方奶粉及其生产方法 | |
CN101317684A (zh) | 一种固体饮料及制作方法 | |
CN102894372A (zh) | 一种增加骨密度的保健食品及其制备方法 | |
CN101141888A (zh) | 促进减肥的辅助性膳食组合物 | |
CN104382055A (zh) | 一种胶原蛋白粉 | |
CN104206949A (zh) | 改善骨质疏松、增加骨密度的组合物、其制备方法及其在制备保健品上的应用 | |
CN101720928A (zh) | 一种防治骨骼及关节退行性疾病的组合物 | |
CN110973638A (zh) | 一种晶合胶囊及其制作工艺 | |
CN104824677A (zh) | 一种增加骨密度的保健食品及其制备方法 | |
CN103330197A (zh) | 改善骨质疏松症的保健食品 | |
CN104001157B (zh) | 一种防治骨质疏松症的复方制剂及其制备方法 | |
CN105595327A (zh) | 一种航天员专用的柠檬酸钙制剂 | |
CN104738623A (zh) | 一种富含维生素k2和钙剂的香菇粉胶囊及其制备方法 | |
CN102626463A (zh) | 一种增加骨密度、防治骨质疏松症的天然药物组合物 | |
RU2205655C1 (ru) | Средство для профилактики и лечения мочекаменной болезни | |
CN1565231A (zh) | 一种蜂蜜制品的配方 | |
CN102524800A (zh) | 一种复合黄瓜籽粉及其制备方法 | |
CN114081188A (zh) | 一种骨肽复合食品的组方及制备方法 | |
CN112042946A (zh) | 富含益生元的高钙组合物及其制备方法 | |
CN103238839A (zh) | 用于保养关节的含胶原蛋白的食品组成物 | |
CN103704684A (zh) | 一种骨骼保健品 | |
CN106954802A (zh) | 一种预防退行性骨关节病的保健食品 | |
CN107115424B (zh) | 改变酸性体质保钙及清热解毒的中药组合物及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200410 |
|
RJ01 | Rejection of invention patent application after publication |